A clinician’s handbook for using ctDNA throughout the patient journeySamantha O. Hasenleithner, Michael R. Speicher|Molecular Cancer|2022Cited by 106
On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancerTina Moser, Michael R. Speicher, Julie Waldispuehl‐Geigl et al.|npj Precision Oncology|2020Cited by 26
Clinical applications of next‐generation sequencing‐based <scp>ctDNA</scp> analyses in breast cancer: defining treatment targets and dynamic changes during disease progressionEva Valentina Klocker, Michael Gnant, Ellen Heitzer et al.|Molecular Oncology|2024Cited by 15
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trialJakob M. Riedl, Armin Gerger, Samantha O. Hasenleithner et al.|Therapeutic Advances in Medical Oncology|2021Cited by 10
Metadata record for the manuscript: On-treatment measurements of circulating tumor DNA during FOLFOX therapy in patients with colorectal cancerTina Moser, Michael R. Speicher, Julie Waldispuehl‐Geigl et al.|Figshare|2020Cited by 0